US 11078485
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted A61KA61K48/005
Quick answer
US patent 11078485 (Compositions comprising alternating 2′-modified nucleosides for use in gene modulation) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K48/005